Author: Healio ophthalmology

ACP, AAFP express concerns about Trump’s ‘skinny’ budget proposal

by  •  • 0 Comments

The ACP and the American Academy of Family Physicians recently released statements about President Donald J. Trump Administration’s Fiscal Year 2018 budget outline, voicing deep concerns about its proposed reductions to medical and health services research, primary care training programs and many other essential health care programs and research, as well as its implications for patients’ health, safety and access to care. “The United States has long been recognized as a world leader in medical research and education,” Nitin S. Damle, MD, MS, MACP, president of ACP, said in a (Read more...)

Study highlights potential of alternative anti-inflammatory agent

by  •  • 0 Comments

A single postoperative injection of XG-102 was non-inferior to dexamethasone eye drops in the management of surgery-induced ocular inflammation in a phase 2 randomized, controlled trial. The study, which was carried out at six sites in France, randomized 145 eyes of 145 patients undergoing anterior or posterior segment surgery into three groups, receiving XG-102 (brimapitide, Xigen) 90 µg, XG-102 900 µg or dexamethasone eye drops administered four times a day for 21 days. XG-102 was administered by subconjunctival injection at the end of surgery.

Read more →

AMA, ACS, AHA, ADA to Congress: Slow down, reconsider AHCA

by  •  • 0 Comments

At a recent National Press Club event, the AMA, American Cancer Society Cancer Action Network, American Diabetes Association and American Heart Association expressed concerns regarding President Donald J. Trump’s proposed health care law, the American Health Care Act. The groups emphasized the negative impact the act will have on millions of Americans, particularly those with chronic health conditions, including cancer, diabetes, heart disease and stroke.Earlier this week, the Congressional Budget Office (CBO) released a report that projected the American Health Care Act (AHCA) will cause millions of Americans to lose (Read more...)

AMA approves extensions for three Category III CPT codes for MIGS devices

by  •  • 0 Comments

The AMA has granted a 5-year extension to three Category III CPT codes that describe insertion of aqueous drainage devices into the anterior chamber of the eye using microinvasive glaucoma surgery, according to a Glaukos press release.The extension, good through Dec. 31, 2023, includes 0191T, which describes the insertion of an initial anterior segment aqueous drainage device into the trabecular meshwork, such as Glaukos’ iStent; 0253T, which describes insertion of an anterior segment aqueous drainage device into the suprachoroidal space, such as the iStent Supra; and 0376T, which is an (Read more...)

Woman presents with cloudy declining vision and flashes

by  •  • 0 Comments

A 56-year-old Caucasian woman presented with painless, slowly decreasing “murky” vision in the left eye over a period of 3 weeks, along with flashes. Her ocular history was positive for hemorrhagic posterior vitreous detachment after blunt trauma with a basketball to the same eye 4 months earlier. On that exam, she was also noted to have “fullness of the optic nerve, venous beading and inferior drusen OS.” Despite the physician’s recommendation to return after 4 to 6 weeks, the patient was lost to follow-up until new visual symptoms started. She (Read more...)